Catalyst Wire Dossier Catalyst Wire Dossier

Bicalutamide (Casodex)

bicalutamide · AstraZeneca
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bicalutamide (Casodex), covering 2017-05-24 to 2017-05-24. Get the full timeline:

Most recent: Clinical Trial Update: Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy [Phase 2]

See pricing